Position in AZN
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$997,021
-$95,972 QoQ
Shares Held
5,258
-5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#674
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMCG INVESTMENTS, LLC holds $114,362,814 across 9 Drug Manufacturers - General names. AZN ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
139,806 | $35,180,781 | |
| 2 | LLY |
ELI LILLY & Co
|
20,478 | $24,561,929 | |
| 3 | JNJ |
Johnson & Johnson
|
74,070 | $18,811,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
141,678 | $18,205,623 | |
| 5 | AMGN |
Amgen Inc
|
35,923 | $13,008,436 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
17,512 | $2,212,466 | |
| 7 | PFE |
Pfizer Inc
|
43,942 | $1,058,123 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
5,258 | $997,021 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $997,021 | 5,258 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,092,993 | 5,542 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||